2,818
Views
9
CrossRef citations to date
0
Altmetric
Plenary Paper

Investigation of the contribution of an underlying platelet defect in women with unexplained heavy menstrual bleeding

, , , , ORCID Icon, , ORCID Icon, , & ORCID Icon show all
Pages 56-65 | Received 01 Oct 2018, Accepted 29 Oct 2018, Published online: 06 Dec 2018

References

  • Quinn SD, Higham J. Outcome measures for heavy menstrual bleeding. Women’s Health (London, England) 2016 Jan;12(1):21–26. doi:10.2217/whe.15.85
  • Wyatt KM, Dimmock PW, Walker TJ, O’Brien PM. Determination of total menstrual blood loss.Fertil Steril 2001;76(1):125–131.
  • Kirkwood-Wilson R, Bardapure J, Das S. Is heavy menstrual bleeding investigated and managed appropriately? J Obstet Gynaecol 2013 Apr;33(3):282–284. doi:10.3109/01443615.2012.750287
  • Peyvandi F, Garagiola I, Menegatti M. Gynecological and obstetrical manifestations of inherited bleeding disorders in women. J Thromb Haemostasis 2011;9:236–245. doi:10.1111/j.1538-7836.2011.04372.x
  • Munro MG, Critchley HO, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011 Apr;113(1):3–13. doi:10.1016/j.ijgo.2010.11.011
  • NICE. Heavy menstrual bleeding: assessment and management (update) Retrieved from http://www.nice.org.uk/NG88. 2018.
  • Quiroga T, Mezzano D. Is my patient a bleeder? A diagnostic framework for mild bleeding disorders. Hematology Am Soc Hematol Educ Program 2012;2012:466–474. doi:10.1182/asheducation-2012.1.466
  • Philipp DA, Miller CH, Evatt B, Baranwal A, Schwartz R, Bachmann G, Saidi P. Platelet functional defects in women with unexplained menorrhagia.J Thromb Haemostasis 2003;1(3):477–484.
  • Miller CH, Philipp CS, Stein SF, Kouides PA, Lukes AS, Heit JA, Byams VR, Dowling NF, Kulkarni R. The spectrum of haemostatic characteristics of women with unexplained menorrhagia. Haemophilia 2011 Jan;17(1):e223–9. doi:10.1111/hae.2010.17.issue-1
  • Matthews DC. Inherited disorders of platelet function.Pediatr Clin North Am 2013;60(6):1475. doi:10.1016/j.pcl.2013.08.004
  • Watson SP, Lowe GC, Lordkipanidze M, Morgan NV. Genotyping and phenotyping of platelet function disorders. J Thromb Haemost 2013 Jun;11(Suppl 1):351–363. doi:10.1111/jth.12199
  • Lowe GC, Lordkipanidze M, Watson SP. Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. J Thromb Haemost 2013 Sep;11(9):1663–1668. doi:10.1111/jth.12332
  • Dawood BB, Lowe GC, Lordkipanidze M, Bem D, Daly ME, Makris M, Mumford A, Wilde JT, Watson SP. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood 2012 Dec 13;120(25):5041–5049. doi:10.1182/blood-2012-07-444281
  • Balta S, Demirkol S, Cakar M, Celik T. Mean platelet volume as a surrogate marker of low-grade inflammation in osteoarthritis.Platelets 2014;25(8):643–644. doi:10.3109/09537104.2013.786824
  • Bancroft AJ, Abel EW, McLaren M, Belch JJ. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets 2000 Nov;11(7):379–387.
  • Dawood BB, Wilde J, Watson SP. Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: effect of inhibition of ADP and thromboxane A(2) pathways. Platelets 2007 Aug;18(5):329–345. doi:10.1080/09537100601024111
  • Lowe G Phenotyping and genotyping of platelet defects in patient populations enriched in bleeding. PhD thesis, University of Birmingham. 2015.
  • Miller JL. Iron deficiency anemia: a common and curable disease. Cold Spring Harb Perspect Med 2013 Jul 1;3(7). doi:10.1101/cshperspect.a015511
  • Rodeghiero F, Tosetto A, Castaman G. How to estimate bleeding risk in mild bleeding disorders. J Thromb Haemost 2007 Jul;5(Suppl 1):157–166. doi:10.1111/j.1538-7836.2007.02520.x
  • de Wee EM, Sanders YV, Mauser-Bunschoten EP, van der Bom JG, Degenaar-Dujardin ME, Eikenboom J, de Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Hamulyak K, et al. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease. Thromb Haemost 2012 Oct;108(4):683–692. doi:10.1160/TH12-04-0244
  • Philipp CS, Faiz A, Heit JA, Kouides PA, Lukes A, Stein SF, Byams V, Miller CH, Kulkarni R. Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia. Am J Obstet Gynecol 2011 Mar;204(3):209.e1–7. doi:10.1016/j.ajog.2010.10.897
  • Quiroga T, Goycoolea M, Panes O, Aranda E, Martinez C, Belmont S, Munoz B, Zuniga P, Pereira J, Mezzano D. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 2007 Mar;92(3):357–365.
  • Eising HP, Roest M, de Groot PG, Huskens D, Konings J, Urbanus RT, de Laat B, Remijn JA. High prevalence of reduced thrombin generation and/or decreased platelet response in women with unexplained heavy menstrual bleeding. Int J Lab Hematol 2018 Jun;40(3):268–275. doi:10.1111/ijlh.12775
  • Rocheleau AD, Khader A, Ngo ATP, Boehnlein C, McDavitt C, Lattimore S, Recht M, McCarty OJT, Haley KM. Pilot study of novel lab methodology and testing of platelet function in adolescent women with heavy menstrual bleeding. Pediatr Res 2018 Mar;83(3):693–701. doi:10.1038/pr.2017.298